Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Jan;9(1):28-39.
doi: 10.1038/nrc2559.

Targeting cancer with small molecule kinase inhibitors

Jianming Zhang  1 , Priscilla L Yang, Nathanael S Gray
Affiliations
Review

Targeting cancer with small molecule kinase inhibitors

Jianming Zhang et al. Nat Rev Cancer. 2009 Jan.

Abstract

Deregulation of kinase activity has emerged as a major mechanism by which cancer cells evade normal physiological constraints on growth and survival. To date, 11 kinase inhibitors have received US Food and Drug Administration approval as cancer treatments, and there are considerable efforts to develop selective small molecule inhibitors for a host of other kinases that are implicated in cancer and other diseases. Herein we discuss the current challenges in the field, such as designing selective inhibitors and developing strategies to overcome resistance mutations. This Review provides a broad overview of some of the approaches currently used to discover and characterize new kinase inhibitors.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nat Biotechnol. 2008 Jan;26(1):127-32 - PubMed
    1. J Med Chem. 2008 Aug 28;51(16):4986-99 - PubMed
    1. Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10700-5 - PubMed
    1. Nat Biotechnol. 2005 Mar;23(3):329-36 - PubMed
    1. J Med Chem. 1997 Jul 18;40(15):2296-303 - PubMed

MeSH terms

LinkOut - more resources